ADVFN ADVFN

Hot Features

Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
Organon & Co

Organon & Co (0A9W)

0,00
0,00
(0,00%)
Fermé 03 Juillet 5:30PM

Organon & Co (0A9W) Action

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Premium

Statistiques et détails clés

Dernier
-
( - )
Prix Achat
0,00
Prix Vente
0,00
Volume échangé
0,00
0,00 Fourchette du Jour 0,00
0,00 Plage de 52 semaines 0,00
Cap du marché
Clôture Veille
0,00
Ouverture
-
Dernière Transaction
(O)
Dernière heure de transaction
Volume financier
-
VWAP
-
Volume moyen (3 m)
US$ 8 437 632
Actions en circulation
262 600 862
Rendement du Dividende (LTM)
0,08 (0,60%)
Ratio Cours sur Bénéfices
14,36
Bénéfice par action (BPA)
0,94
Chiffre d'affairess (LTM)
6,16B
Bénéfice net (LTM)
246M

À propos de Organon & Co

Organon & Co. develops and delivers women health solutions through prescription therapies and medical devices in the United States, Europe, Canada, Japan, rest of the Asia Pacific, China, Latin America, the Middle East, Russia, Africa, and internationally. The company's women’s health portfolio comp... Organon & Co. develops and delivers women health solutions through prescription therapies and medical devices in the United States, Europe, Canada, Japan, rest of the Asia Pacific, China, Latin America, the Middle East, Russia, Africa, and internationally. The company's women’s health portfolio comprises contraception and fertility brands, such as Nexplanon, a long-acting reversible contraceptive; NuvaRing, a monthly vaginal contraceptive ring; Cerazette, Marvelon, and Mercilon to prevent pregnancy; Follistim AQ, which is used to promote development of ovarian follicles; Elonva, a follicle stimulant; Ganirelix acetate injection, an injectable antagonist; Jada for abnormal postpartum uterine bleeding and hemorrhage; and Xaciato for bacterial vaginosis. Its biosimilars portfolio consists of immunology products, such as Brenzys, Renflexis, and Hadlima; oncology products, including Ontruzant and Aybintio; Bildyos and Bilprevda, a recombinant anti-RANKL human monoclonal antibodies; and Poherdy, a neu receptor antagonist. The company also offers cholesterol-modifying medicines under the Zetia, Ezetrol, Vytorin, Inegy, Atozet, Rosuzet, and Zocor brands; Cozaar and Hyzaar for hypertension; respiratory products to control and prevent asthma symptoms under the Singulair, Dulera, Zenhale, and Asmanex brands, as well as seasonal allergic rhinitis under the Nasonex, Clarinex, and Aerius brands. In addition, it provides dermatology products under the Vtama, Diprosone, and Elocon brand; bone health products under the Fosamax brand; and non-opioid pain management products under the Arcoxia, Diprospan, and Celestone brands, as well as Proscar for symptomatic benign prostatic hyperplasia; and Propecia for male pattern hair loss. The company serves drug wholesalers and retailers, hospitals, clinics, government agencies, health maintenance organizations, pharmacy benefit managers, and other institutions. Organon & Co. was founded in 1923 and is headquartered in Jersey City, New Jersey. Show more

Secteur
-
Industrie
-
Site Web
Siège social
Jersey City, United States
Fondé
2026
Organon & Co est coté dans le secteur de la London Stock Exchange avec le ticker 0A9W. Le dernier cours de clôture d'Organon & était de US$0,00. Au cours de la dernière année, les actions de Organon & ont été négociées dans une fourchette de prix de US$ 0,00 à US$ 0,00.

Organon & compte actuellement 262 600 862 actions en circulation. Organon & a un ratio cours/bénéfice (ratio PE) de 14.36.

0A9W Dernières nouvelles

Aucune actualité à afficher pour le moment.
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10000000DE
40000000DE
120000000DE
260000000DE
520000000DE
1560000000DE
2600000000DE

0A9W - Frequently Asked Questions (FAQ)

What is the current Organon & Co share price?
The current share price of Organon & Co is US$ 0,00
How many Organon & Co shares are in issue?
Organon & Co has 262 600 862 shares in issue
What is the 1 year trading range for Organon & Co share price?
Organon & Co has traded in the range of US$ 0,00 to US$ 0,00 during the past year
What is the PE ratio of Organon & Co?
The price to earnings ratio of Organon & Co is 14,36
What is the cash to sales ratio of Organon & Co?
The cash to sales ratio of Organon & Co is 0,58
What is the registered address of Organon & Co?
The registered address for Organon & Co is 30 Hudson Street, Jersey City, New Jersey, 07302
What is the Organon & Co website address?
The website address for Organon & Co is www.organon.com

0A9W Transactions

Plus

Transactions différées

Pour obtenir des transactions en temps réel, améliorez votre compte

Passer à la version en temps réel
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock